Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Kwality Pharmaceuticals: Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011
News Announcement

Kwality Pharmaceuticals: Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011

11-Jun-2022 Follow Value Research Online on Google download pdfDownload PDF Kwality Pharma

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditya Arora

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.